NCT05670002 is a NA clinical trial of Milk supplement in At Risk or Stunted Children, sponsored by FrieslandCampina.

Who is sponsoring NCT05670002?

NCT05670002 is sponsored by FrieslandCampina.

What drugs are being tested in NCT05670002?

Interventions in NCT05670002: Milk supplement.

What condition does NCT05670002 study?

NCT05670002 studies At Risk or Stunted Children.

Is NCT05670002 still recruiting?

NCT05670002 is currently completed. Last updated 12 March 2025.

Last reviewed 2025-03-12 · How we verify

NCT05670002

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nutrition Intervention of Complementary Milk Feeding to Improve Linear Growth of at Risk and Stunted Children

Completed NA Last updated 12 March 2025

What this trial tests

NA trial testing Milk supplement in At Risk or Stunted Children in 118 participants. Completed in 25 March 2024.

Timeline

30 November 2022

Primary endpoint
25 March 2024

25 March 2024

Quick facts

Lead sponsor	FrieslandCampina
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	118
Start date	30 November 2022
Primary completion	25 March 2024
Estimated completion	25 March 2024
Sites	1 location across Malaysia

Drugs / interventions tested

Milk supplement

Conditions studied

At Risk or Stunted Children — all drugs for At Risk or Stunted Children →

Sponsor

FrieslandCampina — full company profile →

Who can join

Adults 12 Months to 36 Months, any sex, with At Risk or Stunted Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a non-randomized open label 6 months intervention study that aims to assess the effectiveness of consuming milk daily for 6 months will improve the linear growth rate of children aged 12-36 months.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of an Oral Nutrition Supplement on the Nutritional Status of Stunted and At-Risk of Stunting Children: A Community-Based Intervention Trial
Al-Talib S, Jan Mohamed H, Mitra A, Rostenberghe H, et al · · 2026

Verify or expand the search:

Other FrieslandCampina trials

Trials by the same sponsor.

NCT07242508 — Efficacy of a New Infant Formula Composition on Gut Health in Infants · NA · not yet recruiting
NCT06251427 — Assessing the Effectiveness of a Multiple-micronutrient Fortified Maize Pap on the Nutrient Status of Nigerian School-ag · NA · completed
NCT05813769 — Dairy and Plant Amino Acid Uptake. An Explorative Study · NA · completed
NCT05418491 — The Prolonged Effect of Consumption of a Partially Hydrolyzed Infant Formula During the First 6 Months of Life on the De · completed
NCT05372601 — Prebiotics and Stress Reduction in Women · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05670002 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by FrieslandCampina
Last refreshed: 12 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05670002.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing